{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:57:09Z","timestamp":1793429829753,"version":"4.5.0"},"reference-count":115,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/pap.0b013e3181e4abdb","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T01:40:36Z","timestamp":1277084436000},"page":"251-261","source":"Crossref","is-referenced-by-count":71,"title":["Ocular Adnexal Lymphomas: A Review"],"prefix":"10.1097","volume":"17","author":[{"given":"Penelope A.","family":"McKelvie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/1097-0142(19940501)73:9<2395::AID-CNCR2820730924>3.0.CO;2-V","article-title":"Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma","volume":"73","author":"Bairey","year":"1994","journal-title":"Cancer"},{"key":"R2-2-20210202","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#","article-title":"Occurrence and prognosis of extranodal lymphoma","volume":"29","author":"Freeman","year":"1972","journal-title":"Cancer"},{"key":"R3-2-20210202","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djj248","article-title":"Rapidly increasing incidence of ocular non-Hodgkin lymphoma","volume":"98","author":"Moslehi","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009","journal-title":"Blood"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood-2006-02-005017","article-title":"Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options","volume":"108","author":"Decaudin","year":"2006","journal-title":"Blood"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0046-8177(90)90181-4","article-title":"Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987","volume":"21","author":"Knowles","year":"1990","journal-title":"Hum Pathol"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00002341-199905000-00006","article-title":"Ocular adnexal lymphoid tumors: a clinicopathologic and molecular genetic study of 77 patients","volume":"15","author":"Johnson","year":"1999","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/S0161-6420(95)30764-6","article-title":"Ocular adnexal lymphoma. A clinicopathologic study with identification of mucosa-associated lymphoid tissue type","volume":"102","author":"White","year":"1995","journal-title":"Ophthalmology"},{"key":"R9-2-20210202","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0161-6420(98)98024-1","article-title":"Lymphoproliferative lesions of the ocular adnexa","volume":"105","author":"Coupland","year":"1998","journal-title":"Ophthalmology"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bjo.84.8.907","article-title":"Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival","volume":"84","author":"Jenkins","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1442-9071.2001.d01-18.x","article-title":"Ocular adnexal lymphoproliferative disease: a series of 73 cases","volume":"29","author":"McKelvie","year":"2001","journal-title":"Clin Exp Ophthalmol"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0360-3016(03)00767-3","article-title":"Ocular adnexal lymphoma: clinical behaviour of distinct world Health Organization classification subtypes","volume":"57","author":"Fung","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-2-20210202","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hon.741","article-title":"Ophthalmologic and intraocular non-Hodgki\u0144s lymphoma: a large single centre study of initial characteristics, natural history and prognostic factors","volume":"22","author":"Meunier","year":"2004","journal-title":"Hematol Oncol"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.IOP.0000159173.42243.AD","article-title":"Lymphoproliferative disease of the ocular adnexa: a clinical and pathologic study with statistical analysis of 69 patients","volume":"21","author":"Sullivan","year":"2005","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R15-2-20210202","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/bjo.85.1.63","article-title":"Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification","volume":"85","author":"Auw-Haedrich","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R16-2-20210202","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00417-003-0831-5","article-title":"Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases","volume":"42","author":"Coupland","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R17-2-20210202","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/bjo.2004.047092","article-title":"Plasmacellular differentiation in extranodal marginal zone B-cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases","volume":"89","author":"Coupland","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajh.10332","article-title":"Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients","volume":"73","author":"Cho","year":"2003","journal-title":"Am J Hematol"},{"key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.pas.0000213350.49767.46","article-title":"Lymphoma of the ocular adnexa: a study of 353 cases","volume":"31","author":"Ferry","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R20-2-20210202","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jjco\/hym031","article-title":"Primary ocular adnexal lymphoma: a long-term follow-up of 114 patients","volume":"37","author":"Tanimoto","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"R21-2-20210202","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/modpathol.3880366","article-title":"Clinical, histopathological and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of MALT lymphoma and reactive lymphoid hyperplasia","volume":"14","author":"Mannami","year":"2001","journal-title":"Mod Pathol"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/IOP.0b013e318030b058","article-title":"Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions","volume":"23","author":"Yoon","year":"2007","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R23-2-20210202","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0161-6420(99)90492-X","article-title":"T-cell and T\/natural killer-cell lymphomas involving ocular and ocular adnexal tissues","volume":"106","author":"Coupland","year":"1999","journal-title":"Ophthalmology"},{"key":"R24-2-20210202","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0161-6420(03)00330-0","article-title":"Ocular adnexal lymphoid proliferations. Clinical, histologic, flow cytometric and molecular analysis of 43 cases","volume":"110","author":"Sharara","year":"2003","journal-title":"Ophthalmology"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.ophtha.2008.02.004","article-title":"Orbital lymphproliferative tumors: analysis of clinical features and systemic involvement in 160 cases","volume":"115","author":"Demirci","year":"2008","journal-title":"Ophthalmology"},{"key":"R26-2-20210202","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0161-6420(98)92107-8","article-title":"Malignant tumors of the orbit. Analysis of the Florida cancer registry","volume":"105","author":"Margo","year":"1998","journal-title":"Ophthalmology"},{"key":"R27-2-20210202","first-page":"214","article-title":"WHO classification of Tumours of the Haemopoietic and Lymphoid Tissues","author":"Isaacson","year":"2008"},{"key":"R28-2-20210202","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.humpath.2006.09.007","article-title":"Orbital marginal zone lymphomas: an immunohistochemical, polymerase chain reaction and fluorescence in situ hybridization study","volume":"38","author":"Schiby","year":"2007","journal-title":"Hum Pathol"},{"key":"R29-2-20210202","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.5858\/2008-132-1405-MFOLOT","article-title":"Morphologic features of 115 lymphomas of the orbit and ocular adnexa categorized according to the World Health Organization classification","volume":"132","author":"Lagoo","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"R30-2-20210202","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ajo.2008.03.013","article-title":"Ocular adnexal lymphoid tumors. Progress in need of clarification","volume":"145","author":"Jakobiec","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R31-2-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/ajcp\/105.1.31","article-title":"CD5+ extranodal marginal zone B-cell lymphoma: a low grade neoplasm with a propensity for bone marrow involvement and relapse","volume":"105","author":"Ferry","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"R32-2-20210202","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"R33-2-20210202","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/annonc\/mdm513","article-title":"Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy","volume":"19","author":"Ferreri","year":"2008","journal-title":"Ann Oncol"},{"key":"R34-2-20210202","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/01.pas.0000249445.28713.88","article-title":"Extranodal marginal zone lymphomas of the ocular adnexa. Multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci","volume":"31","author":"Ruiz","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R35-2-20210202","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood-2005-06-2332","article-title":"Ocular adnexal lymphoma: a clinicopathologic study of a large cohort study of patients with no evidence for an association with Chlamydia psittaci","volume":"107","author":"Rosado","year":"2006","journal-title":"Blood"},{"key":"R36-2-20210202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1440-1827.2004.01580.x","article-title":"No evidence of correlation between BCL10 expression and API2-MALT1 gene rearrangement in ocular adnexal MALT lymphoma","volume":"54","author":"Adachi","year":"2004","journal-title":"Path Intern"},{"key":"R37-2-20210202","first-page":"1052","article-title":"Histopathologic findings and frequency of clonality by the polymerase chain reaction in ocular adnexal lymphoproliferative lesions","volume":"9","author":"White","year":"1996","journal-title":"Mod Pathol"},{"key":"R38-2-20210202","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/10428190109097692","article-title":"Molecular analysis of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa","volume":"42","author":"Chen","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"R39-2-20210202","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-0420.2003.00067.x","article-title":"Lymphoid tumours of the ocular adnexa: a morphologic and genotypic study of 15 cases","volume":"8","author":"Sigurdardottir","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"R40-2-20210202","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00129039-200209000-00013","article-title":"Immunohistochemical detection of immunoglobulin light chain expression in B-cell non-Hodgkin's lymphomas using formalin-fixed paraffin-embedded tissues and a heat-induced epitope retrieval technique","volume":"10","author":"Marshall-Taylor","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R41-2-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/02841860701630283","article-title":"Assessment of the role of hepatitis C, Helicobacter pylori and autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patients","volume":"47","author":"Gruenberger","year":"2008","journal-title":"Acta Oncologica"},{"key":"R42-2-20210202","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1471-2407-6-249","article-title":"Fluorescence in situ hybridization (FISH) analysis of primary ocular adnexal MALT lymphoma","volume":"6","author":"Tanimoto","year":"2006","journal-title":"BMC Cancer"},{"key":"R43-2-20210202","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/01.pas.0000213275.60962.2a","article-title":"The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoma tissue (MALT lymphoma) in north America","volume":"30","author":"Remstein","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R44-2-20210202","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.MP.0000067421.92575.6E","article-title":"Involvement of the chromosomal translocation t(11,18) in some mucosa-associated lymphoid tissue lymphomas and diffuse large B-cell lymphomas of the ocular adnexa. Evidence from multiplex reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization using formalin-fixed paraffin-embedded specimens","volume":"16","author":"Takada","year":"2003","journal-title":"Mod Pathol"},{"key":"R45-2-20210202","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","article-title":"Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites","volume":"18","author":"Streubel","year":"2004","journal-title":"Leukemia"},{"key":"R46-2-20210202","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","article-title":"T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma","volume":"101","author":"Streubel","year":"2003","journal-title":"Blood"},{"key":"R47-2-20210202","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1200\/JCO.2006.06.0723","article-title":"Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience","volume":"24","author":"Raderer","year":"2006","journal-title":"J Clin Oncol"},{"key":"R48-2-20210202","first-page":"2335","article-title":"Variable frequency of t(11;18(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H.pylori in gastric MALT lymphoma","volume":"101","author":"Ye","year":"2003","journal-title":"Blood"},{"key":"R49-2-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3960\/jslrt.47.31","article-title":"MALT lymphoma: recent advances in aetiology and molecular genetics","volume":"47","author":"Du","year":"2007","journal-title":"J Clin Exp Hematopathol"},{"key":"R50-2-20210202","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/gut.2007.123729","article-title":"Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation","volume":"56","author":"Nakamura","year":"2007","journal-title":"Gut"},{"key":"R51-2-20210202","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.humpath.2003.08.007","article-title":"T(14;18)(q32;q21) involving MALT1 and IGH genes in an extranodal diffuse large B-cell lymphoma","volume":"34","author":"Cook","year":"2003","journal-title":"Hum Pathol"},{"key":"R52-2-20210202","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/path.1715","article-title":"MALT lymphoma with t(14;18)(q32;q21)\/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression","volume":"205","author":"Ye","year":"2005","journal-title":"J Pathol"},{"key":"R53-2-20210202","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.leu.2403644","article-title":"T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma","volume":"19","author":"Streubel","year":"2005","journal-title":"Leukemia"},{"key":"R54-2-20210202","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/modpathol.2008.74","article-title":"FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control","volume":"21","author":"Goatly","year":"2008","journal-title":"Mod Pathol"},{"key":"R55-2-20210202","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.1158\/1078-0432.CCR-08-0702","article-title":"Mucosa-associated lymphoid tissue lymphoma: novel translocations involving ODZ2, JMJD2C and CNN3","volume":"14","author":"Vinatzer","year":"2008","journal-title":"Clin Canc Res"},{"key":"R56-2-20210202","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0002-9440(10)64630-5","article-title":"BCL10 expression in normal and neoplastic lymphoid tissue \u2013 nuclear localization in MALT lymphoma","volume":"157","author":"Ye","year":"2000","journal-title":"Am J Pathol"},{"key":"R57-2-20210202","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/modpathol.3800523","article-title":"MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells","volume":"19","author":"Sagaert","year":"2006","journal-title":"Mod Pathol"},{"key":"R58-2-20210202","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/modpathol.3800609","article-title":"Nuclear BCL10 expression is common in lymphoplasmacytic lymphoma\/ Waldenstrom macroglobulinemia and does not correlate with p65 NF-\u03baB activation","volume":"19","author":"Merzianu","year":"2006","journal-title":"Mod Pathol"},{"key":"R59-2-20210202","first-page":"1315","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"19","author":"Ferreri","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R60-2-20210202","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1200\/JCO.2005.07.083","article-title":"Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy","volume":"23","author":"Ferreri","year":"2005","journal-title":"J Clin Oncol"},{"key":"R61-2-20210202","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/annonc\/mdl124","article-title":"Bacteria eradicating therapy for ocular adnexal lymphoma: questions for an open international prospective trial","volume":"17","author":"Ferreri","year":"2006","journal-title":"Ann Oncol"},{"key":"R62-2-20210202","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2796.2009.02083.x","article-title":"Infectious agents and lymphoma development: molecular and clinical aspects","volume":"265","author":"Ferreri","year":"2009","journal-title":"J Intern Med"},{"key":"R63-2-20210202","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.1984","article-title":"Chlamydia psittaci is variably associated with ocular adnexa MALT lymphoma in different geographical regions","volume":"209","author":"Chanudet","year":"2006","journal-title":"J Pathol"},{"key":"R64-2-20210202","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/cncr.22843","article-title":"Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics","volume":"110","author":"Husain","year":"2007","journal-title":"Cancer"},{"key":"R65-2-20210202","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/CAD.0b013e32830b58c4","article-title":"Variable association between Chlamydia psittaci infection and ocular adnexal lymphomas: methodological biases or true geographical variations","volume":"19","author":"Decaudin","year":"2008","journal-title":"Anti-cancer Drugs"},{"key":"R66-2-20210202","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/PAS.0b013e31816148ad","article-title":"Ocular adnexal lymphoma associated with IgG-4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG-4-related sclerosing disease","volume":"32","author":"Cheuk","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R67-2-20210202","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1440-1827.2008.02257.x","article-title":"Ocular adnexal IgG4 related disease has uniform clinicopathology","volume":"58","author":"Sato","year":"2008","journal-title":"Path Intern"},{"key":"R68-2-20210202","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.eye.6700379","article-title":"Clinical features associated with survival of patients with lymphoma of the ocular adnexa","volume":"17","author":"Jenkins","year":"2003","journal-title":"Eye"},{"key":"R69-2-20210202","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0161-6420(01)00547-4","article-title":"Conjunctival lymphoid tumors. Clinical analysis of 117 cases and relationship to systemic lymphoma","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"key":"R70-2-20210202","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-8140(88)90218-6","article-title":"Orbital and conjunctival lymphoma treatment and prognosis","volume":"13","author":"Bessell","year":"1988","journal-title":"Radiother Oncol"},{"key":"R71-2-20210202","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0360-3016(02)04159-7","article-title":"Outcome and prognostic factors in orbital lymphoma: a rare cancer network study on 90 consecutive patients treated with radiotherapy","volume":"55","author":"Martinet","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R72-2-20210202","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10428199909058411","article-title":"Histology according to the revised European American lymphoma classification significantly predicts the prognosis of ocular adnexal lymphoma","volume":"32","author":"Nakata","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"R73-2-20210202","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3928\/15428877-20070701-08","article-title":"Value of positron emission tomography in staging ocular adnexal lymphomas and evaluating their response to therapy","volume":"38","author":"Gayed","year":"2007","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R74-2-20210202","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.eye.6702382","article-title":"Imaging features of ocular adnexal lymphoproliferative disease","volume":"20","author":"Sullivan","year":"2006","journal-title":"Eye"},{"key":"R75-2-20210202","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.ophtha.2006.05.059","article-title":"Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease","volume":"113","author":"Valenzuela","year":"2006","journal-title":"Ophthalmology"},{"key":"R76-2-20210202","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/annonc\/mdl295","article-title":"18-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference","volume":"17","author":"Hoffman","year":"2006","journal-title":"Ann Oncol"},{"key":"R77-2-20210202","first-page":"1860","article-title":"Report of the committee on Hodgki\u0144s disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"R78-2-20210202","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.5858\/133.8.1262","article-title":"A TNM-based clinical staging system of ocular adnexal lymphomas","volume":"133","author":"Coupland","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"R79-2-20210202","article-title":"AJCC Cancer Staging Manual. 7th ed","author":"Coupland","year":"2009"},{"key":"R80-2-20210202","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.ophtha.2006.04.029","article-title":"Whole-body positron emission tomography\/computed tomography imaging and staging of orbital lymphoma","volume":"113","author":"Roe","year":"2006","journal-title":"Ophthalmology"},{"key":"R81-2-20210202","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/10428190500518966","article-title":"Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors","volume":"47","author":"Meunier","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"R82-2-20210202","first-page":"10","article-title":"WHO Classification of Tumours of the Haemopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"R83-2-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0167-8140(95)01658-9","article-title":"A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas","volume":"38","author":"Esik","year":"1996","journal-title":"Radiother Oncol"},{"key":"R84-2-20210202","first-page":"269","article-title":"Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?","volume":"9","author":"Restrepo","year":"1998","journal-title":"Crit Rev Oncog"},{"key":"R85-2-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00277-004-0914-3","article-title":"Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit","volume":"84","author":"Lee","year":"2005","journal-title":"Ann Hematol"},{"key":"R86-2-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/annonc\/mdj025","article-title":"Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma","volume":"17","author":"Tanimoto","year":"2006","journal-title":"Ann Oncol"},{"key":"R87-2-20210202","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0360-3016(02)02966-8","article-title":"Curative radiotherapy for primary orbital lymphoma","volume":"54","author":"Bhatia","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R88-2-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1076\/orbi.21.2.117.7192","article-title":"Results of radiotherapy for orbital and adnexal lymphoma","volume":"21","author":"Liao","year":"2002","journal-title":"Orbit"},{"key":"R89-2-20210202","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0360-3016(01)02729-8","article-title":"Primary radiotherapy for localized MALT lymphoma","volume":"52","author":"Le","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R90-2-20210202","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","article-title":"Radiotherapy for extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa","volume":"98","author":"Uno","year":"2003","journal-title":"Cancer"},{"key":"R91-2-20210202","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2001","journal-title":"J Clin Oncol"},{"key":"R92-2-20210202","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0167-8140(91)90067-Q","article-title":"Results of radiotherapy in patients with stage I orbital non-Hodgkin's lymphoma","volume":"22","author":"Letschert","year":"1991","journal-title":"Radiother Oncol"},{"key":"R93-2-20210202","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0360-3016(94)00416-1","article-title":"Radiation therapy for primary ocular lymphoma","volume":"31","author":"Chao","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R94-2-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(98)00535-5","article-title":"Radiotherapy in the management of orbital lymphoma","volume":"44","author":"Bolek","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R95-2-20210202","first-page":"892","article-title":"Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification","volume":"55","author":"Hasegawa","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R96-2-20210202","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-0420.2006.00822.x","article-title":"Ophthalmic and adnexal complications of radiotherapy","volume":"85","author":"Durkin","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"R97-2-20210202","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/030089169708300509","article-title":"Radiation therapy for stage I primary orbital non-Hodgkin's lymphomas","volume":"83","author":"Erkal","year":"1997","journal-title":"Tumori"},{"key":"R98-2-20210202","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-8140(00)00328-5","article-title":"Orbital lymphoma: radiotherapy outcome and complications","volume":"59","author":"Stafford","year":"2001","journal-title":"Radiother Oncol"},{"key":"R99-2-20210202","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ophtha.2006.01.057","article-title":"Oral chlorambucil for extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit","volume":"113","author":"Ben Simon","year":"2006","journal-title":"Ophthalmol"},{"key":"R100-2-20210202","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s00428-005-0122-0","article-title":"Ocular adnexal marginal zone lymphoma: a clinical study and pathologic study of 23 cases","volume":"448","author":"Charlotte","year":"1002","journal-title":"Virchows Archiv"},{"key":"R101-2-20210202","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/annonc\/mdm457","article-title":"Efficacy of chemotherapy as first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma","volume":"19","author":"Song","year":"2008","journal-title":"Ann Oncol"},{"key":"R102-2-20210202","first-page":"436","article-title":"Localized orbital lymphoma","volume":"82","author":"Galieni","year":"1997","journal-title":"Haematologica"},{"key":"R103-2-20210202","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00277-007-0301-y","article-title":"Rituximab and chlorambucil as first-line treatment for low grade ocular adnexal lymphomas","volume":"86","author":"Rigacci","year":"2007","journal-title":"Ann Hematol"},{"key":"R104-2-20210202","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"key":"R105-2-20210202","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000074641","article-title":"Rituximab for treatment of advanced marginal zone lymphoma of the mucosa associated lymphoid tissue lymphoma","volume":"65","author":"Raderer","year":"2003","journal-title":"Oncology"},{"key":"R106-2-20210202","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1080\/10428190701457949","article-title":"Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma","volume":"48","author":"Lossos","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"R107-2-20210202","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0609.2004.00299.x","article-title":"Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva","volume":"73","author":"Nuckel","year":"2004","journal-title":"Eur J Hematol"},{"key":"R108-2-20210202","first-page":"1578","article-title":"Rituximab in patients with mucosa-associated lymphoid tissue type lymphoma of the ocular adnexa","volume":"90","author":"Ferreri","year":"2005","journal-title":"Haematologica"},{"key":"R109-2-20210202","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00277-006-0134-0","article-title":"Rituximab as first line treatment for MALT lymphoma of the extraocular muscle","volume":"85","author":"Benetatos","year":"2006","journal-title":"Ann Hematol"},{"key":"R110-2-20210202","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/bjo.2007.115626","article-title":"Rituximab for the treatment of extranodal marginal zone lymphoma of the lacrimal gland","volume":"91","author":"Heinz","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R111-2-20210202","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/annonc\/mdn692","article-title":"Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for frontline treatment of early stage extranodal indolent ocular adnexal lymphoma","volume":"20","author":"Esmaeili","year":"2009","journal-title":"Ann Oncol"},{"key":"R112-2-20210202","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/ICU.0b013e32830b1539","article-title":"Targeted monoclonal antibody therapy and radioimmunotherapy for lymphoproliferative disorders of the ocular adnexa","volume":"19","author":"Shome","year":"2008","journal-title":"Curr Opin Opthalmol"},{"key":"R113-2-20210202","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1200\/JCO.2005.02.9025","article-title":"Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT Lymphoma","volume":"24","author":"Gruenberger","year":"2006","journal-title":"J Clin Oncol"},{"key":"R114-2-20210202","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"101","author":"Zucca","year":"2003","journal-title":"Blood"},{"key":"R115-2-20210202","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1440-1827.2006.02063.x","article-title":"CD5-positive mucosa associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma","volume":"57","author":"Tasaki","year":"2007","journal-title":"Pathol Int"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00125480-201007000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:24:26Z","timestamp":1786040666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00125480-201007000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0b013e3181e4abdb","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}